Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

AKTUALNOŚCI >> Mabion S.A. has recruited the last patient for its RA clinical trail

Mabion S.A. has recruited the last patient for its RA clinical trail


As of 30 September 2016, the Management Board of the Company has data showing that the number of patients who have not yet completed the trial added to the number of patients who have already completed the trail and can be subjected to a statistical analysis amount together to a number 13% higher than the number required by the protocol, which is 624.

Maciej Wieczorek, President of the Board of Mabion S.A.: We have completed a very significant stage of the clinical trial for RA, which was possible thanks to the enhanced cooperation between Polish and Ukrainian research centres. We have managed to exceed the number of patients required by the trail protocol. As of now, none of the recruited patients has completed the entire clinical trial procedure, but we are well on our way to finalising the entire process.

Recruitment of the last patient for a clinical trial is not tantamount to its conclusion; the last recruited patients must follow the complete clinical trial procedure (i.a. administration of the drug, analyses and a six-month follow-up period).

© Mabion S.A. all rights reserved Polityka Prywatności